In the BioHarmony Drug Report Database
Lutetium (177lu) oxodotreotide
Lutathera (lutetium dotatate lu-177) is an unknown pharmaceutical. Lutetium dotatate lu-177 was first approved as Lutathera on 2018-01-26. Lutathera’s patent is valid until 2038-07-25 (FDA).
Trade Name
|
Lutathera |
|---|---|
Common Name
|
lutetium dotatate lu-177 |
ChEMBL ID
|
CHEMBL3989924 |
Indication
|
|
Drug Class
|
Antineoplastic agent |
Image (chem structure or protein)